Raymond James sees credit costs taking a bite out of earnings, while Moody’s hikes rating by one notch after $1.05B injection.
NYCB’s stock downgraded to underperform at Raymond James on expectation of rising credit costs
![](https://themarketcrash.net/wp-content/uploads/2022/06/imgpsh_fullsize_anim-9-800x400.png)
Raymond James sees credit costs taking a bite out of earnings, while Moody’s hikes rating by one notch after $1.05B injection.
Comments